Inhibition of cellular NEDDylation partially alters the MHC class I immunopeptidome
J Immunol. 2026 Oct 1;215(10):vkag258. doi: 10.1093/jimmun/vkag258. ABSTRACT Determining how chemotherapeutic drugs alter the MHC class I-associated immunopeptidome is essential for designing rational combinatorial therapies to enhance antitumor CD8+ T-cell activity, such as immune checkpoint inhibitor Abs. We investigated the impact of a first-in-class inhibitor of cellular NEDDylation, MLN4924, on self-peptide presentation using 2 human … Read more